The past 20 years have brought tremendous progress in cancer outcomes with improved screening and new treatments. But with these innovations and our country’s aging population, escalating care costs and quality variation continue to confound the system. As public and private payers seek a framework for high-quality, equitable and affordable cancer treatment in the future, efforts to pursue value-based approaches have occurred in a halting fashion, creating a challenging environment for providers and payers to navigate.